Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61590 | 0.87 | GABRA1 (0.54) | GABRA1GABRB2ALDH1A1SMN1; SMN2LIPG | |
| SCHEMBL14176579 | 0.82 | ALDH1A1 (0.34) | GABRA1GABRB2PTGS2ALDH1A1HSD17B10 | |
| SCHEMBL830766 | 0.82 | ALDH1A1 (0.34) | GABRA1GABRB2ALDH1A1HSD17B10TP53 | |
| SCHEMBL61913 | 0.82 | ALDH1A1 (0.50) | GABRA1GABRB2ALDH1A1HSD17B10LIPG | |
| SCHEMBL28221318 | 0.79 | ALDH1A1 (0.48) | GABRA1GABRB2ALDH1A1HSD17B10LIPG | |
| SCHEMBL20694978 | 0.79 | ALDH1A1 (0.48) | GABRA1GABRB2ALDH1A1HSD17B10LIPG | |
| SCHEMBL31200489 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2 | |
| SCHEMBL24331100 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2ALDH1A1CYP3A4TSHR | |
| SCHEMBL24330450 | 0.79 | RIPK1 (0.36) | GABRA1GABRB2ALDH1A1POLBLIPG | |
| SCHEMBL29515588 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109021022-B | Luminescent diazabenzimidazole carbene metal complexes | UDC 爱尔兰有限责任公司 | 2021-04-16 | — | — | CN | disclosed |
| US-20170331054-A1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC IRELAND LTD (IE) | 2017-11-16 | — | — | US | disclosed |
| US-20170331054-A1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC IRELAND LTD (IE) | 2017-11-16 | — | — | US | disclosed |
| US-20170331054-A1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC IRELAND LTD (IE) | 2017-11-16 | — | — | US | disclosed |
| EP-3239161-A1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC Ireland Limited (IE) | 2017-11-01 | — | — | EP | disclosed |
| EP-3239161-A1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC Ireland Limited (IE) | 2017-11-01 | — | — | EP | disclosed |
| EP-3027629-B1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC IRELAND LTD (IE) | 2017-06-14 | — | — | EP | disclosed |
| EP-3027629-B1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | UDC IRELAND LTD (IE) | 2017-06-14 | — | — | EP | disclosed |
| US-9673408-B2 | Luminescent diazabenzimidazole carbene metal complexes | UDC IRELAND LIMITED (IE) | 2017-06-06 | — | — | US | disclosed |
| US-9673408-B2 | Luminescent diazabenzimidazole carbene metal complexes | UDC IRELAND LIMITED (IE) | 2017-06-06 | — | — | US | disclosed |
| EP-2187745-A2 | HERBICIDAL COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2010-05-26 | — | — | EP | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1996557-B1 | PYRIDAZINONE COMPOUND AND USE THEREOF AS HERBICIDES | SUMITOMO CHEMICAL CO (JP) | 2010-03-03 | — | — | EP | disclosed |
| US-20090111696-A1 | Pyridazinone Compound and Use Thereof as herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-30 | — | — | US | disclosed |
| WO-2009035145-A2 | HERBICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-19 | — | — | WO | disclosed |
| WO-2009035151-A2 | HERBICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-19 | — | — | WO | disclosed |
| WO-2009035146-A2 | HERBICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-19 | — | — | WO | disclosed |
| EP-1996557-A1 | PYRIDAZINONE COMPOUND AND USE THEREOF AS HERBICIDES | Sumitomo Chemical Company, Limited (JP) | 2008-12-03 | — | — | EP | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007119434-A1 | PYRIDAZINONE COMPOUND AND USE THEREOF AS HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170331054-A1 | LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES | OCIAD1, OCIAD2, CACNA1D | GABRA1 258/4885GABRB2 141/4885PTGS2 3479/4885 |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | GABRA1 991/4885GABRB2 561/4885PTGS2 3544/4885 |
| US-20090111696-A1 | Pyridazinone Compound and Use Thereof as herbicides | PDXK, DDT, PLPBP | GABRA1 2022/4885GABRB2 1958/4885PTGS2 2092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.